A significant involvement of nitric oxide (NO) in the process of keratinocyte proliferation is reported with many divergences. To determine the involvement of NO in the hyperproliferative process of epidermis in vivo, non-selective inhibitor (N G -nitro-L-arginine-methyl ester.HCl: L-NAME) and selective inhibitors for inducible NO synthase (iNOS) and neuronal NO synthase (nNOS) (Aminoguanidine: AG and 7-Nitroindazole: 7-NI, respectively) and a NO-donor (Sodium nitroprusside: SNP) were topically applied twice a day in mice ear treated with multiple applications of croton oil. L-NAME and 7-NI treatments decreased and SNP increased ear edema formation. However, ear weight was reduced in groups that received L-NAME and 7-NI, while the AG and SNP groups presented an increment. The histological evaluation of epidermis thickness showed that all NOS inhibitors were able to prevent the increase in epidermis width caused by croton oil, while SNP contributed to enlargement. The same results were observed in the PCNA staining, where treatments with NOS inhibitors caused a reduction in the number of cells in the epidermis, while SNP caused an enhancement. 7-NI treatment reduced polymorphonuclear and mononuclear leukocytes migration when compared to the control group. The AG application increased the migration of polymorphonuclear and mononuclear cells, while the SNP enhanced only the polymorphonuclear cells. Therefore, in the skin NO produced by nNOS is involved in the control of keratinocyte hyperproliferation, with the contribution of iNOS. In the animal model of cutaneous chronic inflammation by croton oil, NO is involved in the exudation and leukocyte migration, with participation of all three enzymes.
Introduction
The skin comprises approximately 2 m 2 of the human body surface and represents the largest organ in the body, providing the main physical barrier against the environment. Keratinocytes are the predominant cell type in the epidermis (covering 90% of the cells) and are responsible for the maintenance of the keratin barrier. These cells are also biochemically active, supporting other cellular components of the epithelial microenvironment (Spellberg, 2000) . They form a mechanical barrier, which also functions as an immunological defence against pathogens and noxious stimuli from the environment, and prevent water loss by the organism. The epidermis consists of several layers of keratinocytes: the basal layer directly facing the basal membrane, spinous layer, granular layer, and the outermost stratum corneum. The epidermis is a dynamic structure whose integrity depends on a constant production of new cells in the basal layer and their outward migration and differentiation (Gniadecki, 1998) . Nitric oxide (NO) is an important signalling molecule involved in many physiological and pathological processes. NO is synthesised by three types of NO synthases (NOS), neuronal NOS (nNOS), endothelial NOS (eNOS), and inducible NOS (iNOS), all of which are expressed in the skin Cals-Grierson and Ormerod, 2004) . In the skin, NO has been implicated in numerous homeostatic functions, including keratinocyte proliferation, melanogenesis, angiogenesis, wound healing, collagen synthesis, blood flow, vascular tone regulation, neurotransmission, platelet aggregation, warming and other homeostatic mechanisms (Boissel et al., 2004; Brown et al., 2006; Frank et al., 2000; Mayer and Hemmens, 1997; Romero-Graillet et al., 1997) . However, it also mediates pathological conditions, such as immune-mediated skin diseases, and other inflammatory diseases, including sunburn, psoriasis, toxic epidermal necrosis and cutaneous lupus erythematosus (Bruch-Gerharz et al., 2003; Lerner et al., 2000; Paunel et al., 2005) .
In vitro studies demonstrated that low concentrations of NO donors stimulated the proliferation of primary keratinocytes, whereas high concentrations caused cytostatic effects Krischel et al., 1998; Rossi et al., 2000) . Although the addition of a NO donor to the culture medium apparently did not affect the morphology of differentiating epidermal keratinocytes, it generated dramatic effects in dermal fibroblasts as they underwent apoptosis within 6 days. On the other hand, inhibition of endogenous NO production by addition of the NOS inhibitor N G -nitro-L-argininemethyl ester.HCl (L-NAME) had no effect on cultured fibroblasts, but unexpectedly induced apoptosis in differentiating keratinocytes after 5 days (Gallala et al., 2004) . Several reports have focused on the potential of NO to influence the proliferation and differentiation cascade in a number of mammalian cells, but in the case of keratinocytes, all studies are conducted only in cell culture. For a long time it was assumed that NO presented a nonspecific role in defence. However, it is clear that NO plays a key role in the skin response to external stimuli such as heat, ultraviolet (UV) light, response to infection, inflammation, wound healing, and possibly underlying certain pathological conditions. Thus, the aim of this study was to investigate the role of NO upon the hyperproliferation of epidermal keratinocytes by analysing NOS inhibitors and NO donor effects in an animal model of chronic skin inflammation caused by croton oil.
Material and methods

Animals
All procedures were carried out on adult male Swiss mice weighing 25-35 g. Animals were randomly allocated to one of seven groups (n = 10 per group). Food and water were supplied ad libitum and the animals were kept in a 12 h light/dark cycle and in a temperature-controlled room (22 ± 2°C). All animal procedures were performed after approval of the protocol by the Institutional Ethics Committee of Federal University of Paraná and were carried out in accordance with current guidelines for the care of laboratory animals.
Chemicals
Croton oil, Dexamethasone, Tetramethylbenzidine (TMB), 4-Nitrophenyl N-acetyl-β-D-glucosaminide (NAG), Sodium citrate dehydrate, Sodium nitroprusside dehydrate (SNP), Glycine anhydride, Hexadecyltrimethylammonium Bromide (HTAB) and Albumin from serum bovine (BSA) were purchased from Sigma Chemical Co (St. Louis MO); DAB substrate Kit was purchased from BD Biosciences (San Diego, CA, USA); Acetone, Aminoguanidine (AG), Formaldehyde, Glacial acetic acid, Paraffin, and Phosphate-buffered saline (PBS) were purchased from Merck Biosciences (Germany); Sodium acetate Anhydrous P.A., Hydrogen peroxide, Absolute ethanol, Eosin, Hematoxylin and Xylene were purchased from Vetec (Rio de Janeiro, Brazil); N G -nitro-L-arginine-methyl ester.HCl (L-NAME) was purchased from Alexis Biochemicals-Enzo Life Sciences International, Inc. (Plymouth Meeting, PA, USA); 7-Nitroindazole (7-NI) was purchased from A.G. Scientific, Biochemical Manufacturer (San Diego, CA, USA); Antibody anti-PCNA (C-20) goat polyclonal IgG and Antibody donkey anti-goat IgG HRP were purchased from Santa Cruz Biotechnology, Inc. (CA, USA).
Animal protocol
The chronic inflammatory process was induced by multiple application of croton oil (0.4 mg/ear) for nine days on alternate days. The mice were topically treated with the N G -nitro-L-arginine-methyl ester.HCl (L-NAME) (10 μmol/ear), Aminoguanidine (AG) (10 μmol/ear), Sodium nitroprusside dehydrate (SNP) (2.5 μmol/ear), 7-Nitroindazole (7-NI) (10 μmol/ear) or Dexamethasone (0.1 mg/ear). The animals were treated twice daily from the fifth day and the edema was expressed as the increase in ear thickness (mm), assessed daily using a digital micrometer (Great, MT-04513). To minimise variations in the technique, the experiments were always performed by a single investigator. The croton oil, dexamethasone and 7-NI were dissolved in 20 μl of acetone while L-NAME, AG and SNP were dissolved in 20 μl of water-acetone (5% v/v) applied in the right ear of each mice.
On the last day of the experiment the animals were killed by cervical dislocation and 6 mm circles of ear tissue were collected, weighted and submitted to the assessment of the histological and immunohistochemistry (PCNA) analysis (n = 5 per group) and myeloperoxidase (MPO) and N-acetyl-β-D-glucosaminidase (NAG) enzymatic activity (n = 5 per group).
Histological assessment of epidermis
Ear samples collected from mice were fixed in solution ALFAC (ethanol 80%, formalin 40% and glacial acetic acid). The ears were then dehydrated, embedded in paraffin and sectioned into slices of 5 μm. Slices were hydrated in xylene and a descending sequence of ethanol, then stained with hematoxylin and eosin. To evaluate the epidermis thickness, slices were photographed in increments of 200× and the photographs analysed with the ImageJ software version 1.41 (National Institute of Health, USA). Epidermis thicknesses are expressed in μm.
Immunohistochemical assessment of proliferation cell
Sections (5 μm) of ALFAC-fixed, paraffin-embedded tissue were cut onto silanised glass slides and deparaffinised two times with xylene for 10 min each and rehydrated through a graded alcohol bath. To block radical aldehyde, each section was treated with glycine (0.1 M) for 2 min and to block endogenous peroxidase it was treated with 3% hydrogen peroxide in methanol for 10 min. Slices were treated with phosphate-buffered saline (PBS) containing 1% bovine serum albumin (BSA) for 30 min to diminish non-specific staining. For the detection of Proliferating Cell Nuclear Antigen (PCNA), slides were incubated with 1:100 dilutions of a polyclonal anti-PCNA antibody (Santa Cruz Biotechnology, Inc, USA) in PBS/BSA 1% at room temperature in a moist chamber for 2 h, after this time they were washed with PBS/BSA 1%. Subsequently, the sections were incubated using secondary antibody IgG HRP (Santa Cruz Biotechnology, Inc, USA) diluted 1:100 in PBS/BSA 1% at room temperature in a moist chamber for 1 h. The peroxidase-binding sites were detected by staining with Kit substrate of DAB and incubated for 15 min. Between all steps the sections were washed twice in PBS. Finally, the slides were dehydrated and mounted.
Myeloperoxidase enzymatic activity assay
To assess the enzyme activity, the methodology used was firstly described by (Bradley et al., 1982) and modified by (De Young et al., 1989) . The biopsies (6 mm circles of tissue) were added in 0.75 ml of 80 mM PBS pH 5.4 containing 0.5% of HTBA and homogenised (45 s at 0°C) in a motor-driven homogeniser. The homogenate was decanted into microtubes and added to 0.75 ml of buffer previously described. The samples (1.5 ml) were placed in microfuge tubes and centrifuged at 11.200 ×g at 4°C for 20 min. Triplicates of 30 μl of the supernatant were placed on a 96-well plate, to which 200 μl of a mixture containing 100 μl of 80 mM PBS pH 5.4, 85 μl of 0.22 M PBS pH 5.4 and 15 μl of 0.017% hydrogen peroxide into each well was subsequently added. The addition of 20 μl of 18.4 mM TMB in dimethylformamide promoted the beginning of the reaction. The plate was then incubated at 37°C for 3 min and the reaction stopped by addition of 30 μl of 1.46 M sodium acetate, pH 3.0. The enzymatic activity was determined colorimetrically using a plate reader (EL808; BioTech Instruments, INC) set to measure absorbance at 630 nm and expressed as OD/Biopsy.
N-acetyl-β-D-glucosaminidase enzymatic activity assay
For the NAG activity, triplicates of 25 μl of supernatant, previously described in MPO activity, were placed on a 96-well plate and subsequently 100 μl of 50 mM citrate buffer pH 4.5 was added. The reaction was initiated by the addition of 25 μl of 2.24 mM 4-Nitrophenyl N-acetyl-β-D-glucosaminide. The plate was incubated at 37°C for 1 h and the reaction was stopped by addition of 30 μl of 200 nM glycine buffer pH 10.4. The enzymatic activity was determined colorimetrically using a plate reader (EL808; BioTech Instruments, INC) set to measure absorbance at 405 nm and expressed as OD/Biopsy.
Statistic analysis
The results are presented as mean ± S.E.M. The statistical significance between the groups was assessed by means of one-way analysis of variance (ANOVA) followed by post-hoc Newman-Keuls test. The accepted level of significance for the tests was P b 0.05. All tests were carried out using the statistical software GraphPad Prism version 3.03, San Diego California, USA.
Results
Mouse ear edema induced by croton oil
The multiple applications of croton oil (0.4 mg/ear, topical) induced formation of ear edema that starts at 24 h after the first dose and increases with days of treatment, reaching its maximum on day 5, when compared to vehicle group (acetone). All treatments (twice a day, 12 h/12 h, topical) were performed from the 5th until the 9th day of the experiment. Application of dexamethasone (0.1 mg/ear) was able to reduce the edema during throughout the treatment period, starting on the 1st day of treatment when compared to the control group (Fig. 1) . Similarly, the L-NAME group (10 μmol/ear) and 7-NI group (iNOS inhibitor, 10 μmol/ear) showed a reduction in the edema response during the 5 days of treatment when compared to the control group (Fig. 1A and C, respectively ). Specific iNOS inhibitor tested (AG 10 μmol/ear), when topically applied for 5 days, was not able to cause any change in the edema produced by croton oil multiple applications (Fig. 1B) . However, the use of NO donor SNP (2.5 μmol/ear) caused a significant increase in the croton oil- induced ear edema starting on the 3rd day of treatment in comparison to the control (Fig. 1D) .
At the end (9th day of treatment) repeated applications of croton oil promoted a significant increase in ear weight of the control group (24.3 ± 1.4 mg) when compared to naive (8.3 ± 0.2 mg) and vehicle (10.8 ± 0.3 mg) groups. There was a weight reduction of 16.9 ± 4.8%, 44.3 ± 4.6% and 43.8 ± 2.0% in the groups L-NAME, 7-NI and dexamethasone, respectively. On the other hand in groups treated with AG and SNP, there were increases of 24.9 ± 5.7% and 22.0 ± 9.2%, respectively, in ear weight when compared to the control group (Fig. 2) .
Histological assessment of epidermis
Ear samples (6 mm circles of tissue) submitted to multiple applications of croton oil were used to evaluate cellular hyperproliferation of epidermis. Croton oil promoted an increase in epidermis thickness in the control group (133.8± 8.0 μm) when compared to naive (16.8 ± 0.5 μm) and vehicle (26.2 ± 1.3 μm) groups. All inhibitors of NOS tested were able to block this enhancement in epidermis width in 28.2 ± 5.3% (L-NAME), 20.7 ± 5.3% (AG) and 42.0 ± 3.1% (7-NI), as well as dexamethasone (53.5 ± 3.5%). However, when NO donor SNP was used, it promoted an increase of 35.6 ± 5.7% in the epidermis Fig. 3 . Histological representative pictures of transverse slices from mice ears stained with hematoxylin-eosin (increase of 200×, scale of 500 μm) collected after the multiple application of croton oil (0.4 mg/ear). Groups: naive (without treatment), vehicle (water-acetone, 5% v/v), control, L-NAME (10 μmol/ear), AG (10 μmol/ear), 7-NI (10 μmol/ear), SNP (2.5 μmol/ear) and dexamethasone (0.1 mg/ear). Treatments were initiated on the fifth day of the experiment.
thickness when compared to the control group (Fig. 4) . Representative photos from the histological changes of ear tissues after multiple topical applications of croton oil and treatments are presented in Fig. 3. 
Immunohistochemical staining of cell proliferation
Ear tissues blocked in paraffin were used to assess the number of cells in proliferation through immunolabelling with anti-PCNA antibody. Multiple applications of croton oil promoted an increase in the number of proliferating cells in the ear skin of the control group (87.1 ±6.8 cells/ field) when compared with naive (17.8 ±1.7 cells/ field) and vehicle (44.3 ±3.7 cells/field) groups (Fig. 5) . Animals topically treated with L-NAME, AG, 7-NI and dexamethasone presented a reduction in the number of cells in proliferation (57.3± 3.9, 73.3± 2.7, 26.0 ±0.9 and 37.0± 1.8 cells/field, respectively), while in the SNP group it was amplified (100.8 ±6.7 cell/field) when compared to the control group (Fig. 6 ). Fig. 5 shows representative photos of immunohistochemical changes in the cell proliferation pattern in ear tissues after multiple applications of croton oil and respective topical treatments.
Myeloperoxidase enzymatic activity assay
Myeloperoxidase is a polymorphonuclear leukocyte marker and the determination of its activity indicates leukocyte infiltration. As expected, the repeated treatment with croton oil in the ear promoted an increase of myeloperoxidase activity in the control group, when compared to naive and vehicle groups (Fig. 7A ). In the AG and SNPtreated ears, the myeloperoxidase activity was further increased in 52.8± 23.9% and 74.4± 47.9% respectively, while in 7-NI and dexamethasone groups it was reduced in 39.9±10.8% and 47.0 ±3.4% respectively, in comparison to control values. The other treatment with L-NAME was not able to cause any modification in the myeloperoxidase activity when compared to the control group (Fig. 7A) .
N-acetyl-β-D-glucosaminidase enzymatic activity assay
NAG enzymatic activity is used as an indicator of the presence of mononuclear leukocytes in the tissue. The skin inflammation induced by multiple treatments with croton oil promoted an increase of NAG activity in the tissue of control mice when compared with naive and vehicle (Fig. 7B) . Ears treated with 7-NI or dexamethasone showed a decrease in NAG activity of 14.6 ± 6.1% and 34.4 ± 7.2%, respectively in comparison to control results. However, the topical application of AG increased NAG activity by 16.35 ± 6.3% NAG activity induced by repeated skin treatment with croton oil. The other groups (SNP and L-NAME) showed no modification in the NAG activity when compared to the control group (Fig. 7B) .
Discussion
The process of keratinocytes hyperproliferation with abnormal differentiation that leads to a defective barrier formation, aberrant or exaggerated responses to growth factors, vascular changes, and dermal inflammatory cell migration are characteristics of chronic inflammatory cutaneous diseases, such as psoriasis, allergic inflammatory diseases, chronic wounds, among others (Gniadecki, 1998) . Many studies have been conducted in order to understand these diseases and many of them reported a significant involvement of NO in these processes; however, only a few tried to show the involvement of NO in the control of hyperproliferative epidermal process with controversies.
In the present study we demonstrated by an in vivo model that NO has a relevant role in the regulation of hyperproliferative keratinocytes of the epidermis in chronic inflammatory disorders. Therefore we used the model of multiple applications of croton oil to the ear which causes a skin inflammatory and hyperproliferative process in the epidermis. The active constituent of croton oil is the 12-O-tetradecanoylphorbol-13-acetate (TPA), a well-characterised protein kinase C activator and tumour promoter. Topical application of TPA is a valid model to screen for compounds with an anti-inflammatory potentiality. TPA induces oxidative stress, cutaneous inflammation and epidermal hyperplasia due to enhanced keratinocyte proliferation, transforming growth factor-β1 (TGF-β1) and tumour necrosis factor-α (TNFα) production and the formation of LTB 4 with a resultant increase in vascular permeability and neutrophil influx (Jang and Pezzuto, 1998; Murakawa et al., 2006) . In our experiment, treatment with a non-selective inhibitor of NOS (L-NAME) and selective nNOS inhibitor (7-NI) promoted a reduction in formation of edema and weight of mice ears, while the donor of NO (SNP) increased the ear thickness and weight. This effect of NO is probably due to its vasodilator role. It is clearly understood that this effect is involved in a number of inflammatory reactions of the skin causing enhanced vascular permeability, edema, erythema and enhanced cell infiltration via increasing local blood flow in skin microcirculation (Rhodes et al., 2001) . However, treatment with the selective inhibitors for iNOS (AG) did not alter the edema values, suggesting that nNOS and eNOS are probably the NO producers in the edema event. Our results are in accordance with Orita et al. (2011) who showed the involvement of NO in other skin inflammatory processes.
Keratinocytes in the epidermis are formed continuously in the proliferative basal layer and undergo a tightly regulated process of differentiation as they progress upwards and become part of the cornified epithelium. This maturation process consists essentially of keratinisation, morphological and metabolic changes and loss of nucleus (Cals-Grierson and Ormerod, 2004) . Data from our study show a significant reduction in epidermis thickness of animals treated with inhibitors of NOS (L-NAME, AG and 7-NI), and an increase in thickness of the epidermis layer in animals treated with NO donor (SNP), visibly observed on the board with samples of representative histological sections examined (Fig. 3) . These results strongly suggest that iNOS and nNOS might be responsible for NO-induced hyperproliferation of epidermis.
In order to confirm the changes in the epidermis thickness by NO, immunolabelling for PCNA was used, making possible the quantification of keratinocytes in the proliferation process in the epidermis layer. The number of proliferative cells in skin treated with L-NAME, AG and 7-NI was lower when compared to the control group, while the group treated with SNP showed a larger amount of cells in Fig. 4 . Effect of L-NAME (10 μmol/ear), AG (10 μmol/ear), 7-NI (10 μmol/ear), SNP (2.5 μmol/ear), dexamethasone (0.1 mg/ear) and vehicle (water-acetone, 5% v/v) on epidermis thickness in the 9th day after multiple applications of croton oil (0.4 mg/ ear). Treatments were initiated on the fifth day of the experiment. All data shown are mean ± S.E.M. of 12-24 slices stained with hematoxylin-eosin as described previously. The correlation between the groups was verified by analysis of variance (ANOVA) followed by Newman-Keuls post-hoc test. # P b 0.05 was indicative of significance when compared to the vehicle group and *P b 0.05 was indicative of significance when compared to the control group.
proliferation. All three NOS isoforms are expressed in the skin: the calcium-dependent neuronal and endothelial NOS (also called NOS I and III) produces low levels of NO, generally for homeostatic functions, while the inducible NOS (iNOS, or NOS II) generates much higher levels of NO in a calcium-independent manner, and has been considered to be involved in inflammatory and pathological conditions (Alderton et al., 2001; McDonald and Murad, 1996; Michel and Feron, 1997) . In a previous study by Ikeyama et al. (2007) , the activation of nNOS in the barrier disruption was investigated, observing that the NO level increased in the epidermis. They suggested that increasing NO-induced generation of cGMP leads to release of calcium from the internal store, increasing the intracellular calcium level in epidermal keratinocytes and delaying the barrier repair. This way, if this cascade is blocked, for example, by inhibition of NO synthesis or guanylyl cyclase, barrier recovery is accelerated (Ikeyama et al., 2007) . In the present study the results are in accordance with this, since L-NAME and 7-NI treatments significantly reduced the process of hyperproliferative epidermis in vivo. Furthermore, we found that treatment with AG was also able to inhibit the increased proliferation of keratinocytes. We suggest that nNOS is the main enzyme in the NO production in the epidermal hyperproliferation process, with relevant contribution of iNOS.
Several studies have demonstrated that the mechanism of NO involved in the skin inflammatory process is based on its interaction with nuclear factor-kappa B (NF-κB). SNP topically applied into the dorsal skin of mice caused NF-κB activation through degradation of IκBα, and topical application of PDTC, a known inhibitor of NF-κB, Fig. 5 . PCNA immunohistochemical representative pictures of transverse slices from mice ears (increase of 400×, scale of 250 μm) collected on day 9 after the multiple applications of croton oil (0.4 mg/ear). Groups: naive (without treatment), vehicle (water-acetone, 5% v/v), control, L-NAME (10 μmol/ear), AG (10 μmol/ear), 7-NI (10 μmol/ear), SNP (2.5 μmol/ear) and dexamethasone (0.1 mg/ear). Treatments were initiated on the fifth day of the experiment.
resulted in a dose-related suppression of TPA-induced activation of NF-κB, causing a reduction in COX-2 protein expression in mouse skin (Surh et al., 2001) . Finally, Chun and collaborators described that two different NF-κB inhibitors (PDTC and TPCK) suppressed COX-2 expression induced by SNP in mouse skin. They also confirmed the inhibitory effect of SN50, a cell permeable inhibitory peptide of NF-κB translocation, on COX-2 expression in keratinocytes, suggesting that the NO could induce COX-2 expression in mouse skin through NF-kB activation (Chun et al., 2004) . Medeiros et al. (2009) showed that iNOS knockout mice have a remarkable effect on the inflammatory cascade, as indicated by the decrease in the oedematogenic response and in the number of infiltrating inflammatory cells in response to TPA in the mouse ear. The inflammatory effects mediated by iNOS seem to be associated with its ability to stimulate the activation of ERK and p38 MAPK, which in turn controls the transcriptional factors, mainly CREB, c-Jun and NF-κB (Medeiros et al., 2009) . Our results demonstrated the involvement of NO in the keratinocyte hyperproliferative process; although the mechanism of this effect was not investigated in our study, literature data suggest that this effect could include the involvement of NF-κB.
Leukocytes are defence cells and their main function is to protect our body during inflammation. The presence of polymorphonuclear leukocytes is often correlated to evaluation of myeloperoxidase enzymatic activity (Bradley et al., 1982) and mononuclear leukocytes to NAG enzymatic activity. Thus, we have found that in the chronic skin inflammation model NO induction by SNP application led to an increase in polymorphonuclear migration, while a decrease of both myeloperoxidase and NAG activity was observed with 7-NI treatment. Thus, in this case, cell infiltration mediated by NO during the inflammatory process must be due to nNOS activity. We believe that the improvement of the keratinocyte proliferation process is caused especially by the inhibition of NO local synthesis. Although iNOS is the major source of NO in neutrophils and macrophages (Bogdan, 2001) , AG had no effects on cellular migration and it was shown to decrease keratinocyte proliferation. However, 7-NI treatment seems to be acting directly and indirectly in the inflammatory process, since it reduced cell migration, consequently decreasing NO formation by these cells, and, also, attenuating the keratinocytes hyperproliferation. Some authors reported that low NO concentration induced by L-NAME administration may decrease cytokines levels as well as growth factors such as transforming growth factor-beta 1 (TGF-β1). The low levels of TGF-b1 may also contribute to reduced recruitment of inflammatory cells to the injury site (Amadeu and Costa, 2006) .
The expression and activity of NOS isoforms seems to be cellspecific, since these enzymes have a differential compartmentalization in different organs (Villanueva and Giulivi, 2010) . According to Kobayashi (2010) , iNOS, activated in pathological processes, produces a large amount of NO, which may play a harmful role or an effector function. This is common in neutrophils, and perhaps in other cells such as macrophages. Thus, it is clear that NO plays a dual immunoregulatory role in the induction and resolution of inflammation. A small amount of NO can increase the production of chemokines such as MIP-2 and MCP-1, probably via activation of NF-κB, while a large amount of NO can eliminate it. Therefore, the levels of produced NO are of great relevance to the effect played by NO (Kobayashi, 2010) . Thus, we believe that different effects of NO on the skin are also due to the presence of different isoforms of NOS in each skin cell type. Thus, we suggest that NO produced by eNOS and nNOS would be involved especially in edema formation, while the NO produced by iNOS and nNOS would regulates keratinocyte hyperproliferation and cell migration. Fig. 6 . Immunohistochemical assessment of cell proliferation. Effect of L-NAME (10 μmol/ear), AG (10 μmol/ear), 7-NI (10 μmol/ear), SNP (2.5 μmol/ear), dexamethasone (0.1 mg/ear) and vehicle (water-acetone, 5% v/v) on immunohistochemical staining cell proliferation in the 9th day after by multiple applications of croton oil (0.4 mg/ear). Treatments were initiated on the fifth day of the experiment. All data shown are mean ± S.E.M. of cell number evaluated 9-21 slices marked with anti-PCNA antibody as described previously. The correlation between the groups was verified by analysis of variance (ANOVA) followed by Newman-Keuls post-hoc test. . Effect of L-NAME (10 μmol/ear), AG (10 μmol/ear), 7-NI (10 μmol/ear), SNP (2.5 μmol/ear), dexamethasone (0.1 mg/ear) and vehicle (water-acetone, 5% v/v) topically applied on (A) myeloperoxidase and (B) N-acetyl-β-D-glucosaminidase (NAG) activity in supernatants croton oil-treated ear. Ear enzymatic activities were measured at 9th day after multiple treatment with croton oil. All data shown are mean± S.E.M. of 3-6 animals. The correlation between the groups was verified by analysis of variance (ANOVA) followed by Newman-Keuls post-hoc test.
# P b 0.05 was indicative of significance when compared to the vehicle group and *P b 0.05 was indicative of significance when compared to the control group.
